ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 229 filers reported holding ARRAY BIOPHARMA INC in Q2 2018. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,578,000 | +69.7% | 34,065 | -10.7% | 0.18% | +54.4% |
| Q1 2019 | $930,000 | +65.2% | 38,144 | -3.5% | 0.11% | +39.0% |
| Q4 2018 | $563,000 | -20.6% | 39,519 | -15.3% | 0.08% | -16.3% |
| Q3 2018 | $709,000 | +90.6% | 46,669 | +110.5% | 0.10% | +71.9% |
| Q2 2018 | $372,000 | -100.0% | 22,170 | -52.8% | 0.06% | -53.3% |
| Q1 2018 | $766,632,000 | +32.9% | 46,975 | +4.2% | 0.12% | +31.2% |
| Q4 2017 | $576,960,000 | +882.3% | 45,075 | +844.0% | 0.09% | +830.0% |
| Q3 2017 | $58,733,000 | +47.0% | 4,775 | 0.0% | 0.01% | +25.0% |
| Q2 2017 | $39,967,000 | -6.4% | 4,775 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $42,689,000 | – | 4,775 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,459,128 | $234,543,000 | 9.43% |
| APIS CAPITAL ADVISORS, LLC | 490,000 | $6,983,000 | 9.36% |
| BVF INC/IL | 4,744,062 | $67,603,000 | 8.84% |
| First Light Asset Management, LLC | 2,853,826 | $40,667,000 | 6.48% |
| SECTORAL ASSET MANAGEMENT INC | 2,165,767 | $30,862,000 | 4.20% |
| GREAT POINT PARTNERS LLC | 1,850,000 | $26,363,000 | 3.33% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 146,952 | $2,092,000 | 2.46% |
| Birchview Capital, LP | 168,000 | $2,394,000 | 2.26% |
| X-Square Capital, LLC | 180,554 | $2,572,000 | 2.02% |
| FINANCIAL & INVESTMENT MANAGEMENT GROUP LTD | 295,610 | $4,212,000 | 1.54% |